S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
Log in

OTCMKTS:GNWSF - GeneNews Stock Price, Forecast & News

$0.05
+0.01 (+25.00 %)
(As of 02/19/2020 04:00 PM ET)
Today's Range
$0.05
Now: $0.05
$0.05
50-Day Range
$0.02
MA: $0.03
$0.05
52-Week Range
$0.02
Now: $0.05
$0.16
Volume150,000 shs
Average Volume15,535 shs
Market Capitalization$14.75 million
P/E RatioN/A
Dividend YieldN/A
Beta5.05
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. GeneNews Limited was founded in 1998 and is headquartered in Richmond Hill, Canada.

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:GNWSF
CUSIPN/A
CIKN/A
Phone905-209-2030

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$190,000.00
Book Value($0.03) per share

Profitability

Net Income$-3,940,000.00
Net Margins-2,760.90%

Miscellaneous

Employees16
Market Cap$14.75 million
Next Earnings Date2/20/2020 (Estimated)
OptionableNot Optionable

Receive GNWSF News and Ratings via Email

Sign-up to receive the latest news and ratings for GNWSF and its competitors with MarketBeat's FREE daily newsletter.


GeneNews (OTCMKTS:GNWSF) Frequently Asked Questions

What is GeneNews' stock symbol?

GeneNews trades on the OTCMKTS under the ticker symbol "GNWSF."

When is GeneNews' next earnings date?

GeneNews is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for GeneNews.

Has GeneNews been receiving favorable news coverage?

News articles about GNWSF stock have been trending somewhat positive recently, according to InfoTrie. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. GeneNews earned a news sentiment score of 0.7 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for GeneNews.

Who are some of GeneNews' key competitors?

What other stocks do shareholders of GeneNews own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GeneNews investors own include Pure Energy Minerals (PE), OrganiGram (OGI), BBX Capital (BBXTB), Obsidian Energy (OBE), Canopy Growth (CGC), CytRx (CYTR), Athabasca Oil (ATH), Oritani Financial (ORIT), Newmark Group (NMRK) and Menlo Therapeutics (MNLO).

Who are GeneNews' key executives?

GeneNews' management team includes the folowing people:
  • Mr. James R. Howard-Tripp, Exec. Chairman & CEO
  • Ms. Joanna M. Halsey Esq., Gen. Counsel, Chief Compliance Officer & HR Director of IDL
  • Prof. Choong-Chin Liew Ph.D., Co-Founder
  • Mr. Warren Whitehead, Chief Accountant (Age 67)
  • Mr. David Suria, Sr. Scientist

How do I buy shares of GeneNews?

Shares of GNWSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is GeneNews' stock price today?

One share of GNWSF stock can currently be purchased for approximately $0.05.

How big of a company is GeneNews?

GeneNews has a market capitalization of $14.75 million and generates $190,000.00 in revenue each year. GeneNews employs 16 workers across the globe.View Additional Information About GeneNews.

What is GeneNews' official website?

The official website for GeneNews is http://www.genenews.com/.

How can I contact GeneNews?

GeneNews' mailing address is 70 East Beaver Creek Road Unit 30, Richmond Hill A6, L4B 3B2. The company can be reached via phone at 905-209-2030 or via email at [email protected]


MarketBeat Community Rating for GeneNews (OTCMKTS GNWSF)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  131
MarketBeat's community ratings are surveys of what our community members think about GeneNews and other stocks. Vote "Outperform" if you believe GNWSF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNWSF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel